Autologous Adipose Mesenchymal Stem Cell Implantation ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 17 | Multiple system atrophy | 1 |
17. Multiple system atrophy
Clinical trials : 119 / Drugs : 138 - (DrugBank : 44) / Drug target genes : 59 - Drug target pathways : 111
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04876326 (ClinicalTrials.gov) | October 5, 2020 | 25/4/2021 | Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy | Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy | Multiple System Atrophy;Parkinsonism;Multiple System Atrophy, Parkinson Variant | Biological: Autologous Adipose Mesenchymal Stem Cell Implantation;Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation;Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | Indonesia University | NULL | Recruiting | N/A | N/A | All | 15 | N/A | Indonesia |